相关实验视频

Updated: Jul 23, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

对治疗原发性脑瘤的切除后化疗的初步审查

Meaghan McGovern¹, Michaela Scanlon¹, Amanda Stanton²

¹School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

Exploration of targeted anti-tumor therapy

|July 17, 2023

概括

治疗中枢神经系统 (CNS) 瘤是具有挑战性的,因为复发和抵抗. 未来的治疗方法可能将免疫疗法与新兴技术,如低强度聚焦超声波 (LIFU) 结合起来,以改善结果.

科学领域:

神经瘤学神经瘤学
药理学药理学是指药理学的学科.
免疫治疗是一种免疫疗法.

背景情况:

中枢神经系统 (CNS) 瘤在治疗中存在重大挑战,其特点是高复发率和耐药性.
血脑屏障 (BBB) 限制了对脑瘤的治疗疗效.
从历史上看,使用了像temozolomide这样的化剂,但新的方法正在出现.

研究的目的:

为初级脑瘤切除后提供当前治疗策略的概述.
探索新兴的治疗选择和中枢神经系统瘤治疗的未来方向.

主要方法:

审查关于中枢神经系统瘤治疗的当前文献.
对药理学药物,免疫疗法和新技术的讨论.

主要成果:

目前的治疗方法包括化剂和针对免疫路径的单克隆抗体.
未来的战略涉及免疫疗法和先进技术的结合,例如低强度聚焦超声波 (LIFU).

结论:

中枢神经系统瘤的管理需要不断发展的治疗方法来克服耐药性并改善患者的生存率.
免疫疗法和LIFU等技术的进步对未来的治疗模式具有前景.

关键词:

化学疗法药物化学疗法药物血液大脑屏障是什么?初级中枢神经系统瘤初级中枢神经系统瘤

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection

Published on: May 9, 2022

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...